IDX vs NYR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IDX

INTEG DIAG FPO [IDX]

52MEDIUM

NYR

NYRADA CDI FORUS [NYR]

52MEDIUM

Score Breakdown

IDX NYR
Technical
40
47
Catalyst
58
49
Sentiment
50
50
Fundamental
100
46
Momentum
43
67
Risk Gate
34
42

Key Metrics

IDX Metric NYR
$776.0MMarket Cap$101.3M
872KAvg Volume (20d)185K
+1.4%Short InterestN/A
$3.07052-Week High$1.435
$1.90552-Week Low$0.225
-0.5%Daily Change-2.4%
$2.070Entry Price$0.400
+2.1%ROE-71.0%
+1.8%Profit Margin-234.3%

Active Signals

IDX Signals

Stochastic turning bearish from a high level — caution
Knocking on the door of resistance — if it punches through, things could get interesting
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (1.0x)
Strong revenue growth (+56%)
EPS estimates revised upward (+10pts)

NYR Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 4.8% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Low cash runway (4 quarters) - dilution risk
Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare IDX and NYR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IDX Full Analysis → NYR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).